IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ARICI, Bruna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.138
NA - Nord America 2.134
AS - Asia 1.745
SA - Sud America 331
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
AN - Antartide 1
Totale 6.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.069
CN - Cina 658
DE - Germania 630
SG - Singapore 547
PL - Polonia 347
UA - Ucraina 346
BR - Brasile 271
IT - Italia 196
FI - Finlandia 146
HK - Hong Kong 125
FR - Francia 120
IN - India 120
VN - Vietnam 112
RU - Federazione Russa 105
GB - Regno Unito 98
TR - Turchia 61
IE - Irlanda 50
CA - Canada 33
SE - Svezia 33
MX - Messico 26
BD - Bangladesh 25
AR - Argentina 22
BE - Belgio 20
ID - Indonesia 16
EC - Ecuador 13
EU - Europa 13
IQ - Iraq 12
JP - Giappone 10
NL - Olanda 10
PK - Pakistan 10
ZA - Sudafrica 10
ES - Italia 8
AU - Australia 7
PY - Paraguay 7
SA - Arabia Saudita 6
AT - Austria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
IR - Iran 5
KE - Kenya 5
EG - Egitto 4
JO - Giordania 4
NG - Nigeria 4
RO - Romania 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
IL - Israele 2
OM - Oman 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 6.406
Salva come PNG Salva come JPEG
Città #
Warsaw 347
Singapore 299
Jacksonville 239
Ashburn 165
Beijing 140
Hong Kong 122
Chandler 115
Fairfield 114
Woodbridge 105
Ann Arbor 102
The Dalles 98
Nanjing 96
Princeton 96
Helsinki 93
New York 81
Wilmington 81
Houston 73
Cambridge 62
San Jose 52
Dearborn 49
Dublin 49
Los Angeles 48
Istanbul 45
Lauterbourg 43
Seattle 43
Ho Chi Minh City 37
Brescia 35
Nanchang 35
Munich 34
Shenyang 27
Buffalo 26
Changsha 24
Des Moines 24
Tianjin 24
São Paulo 23
Hebei 22
Jinan 20
Milan 19
Orem 18
San Francisco 18
Brussels 17
Hanoi 16
Pune 16
Jiaxing 15
Toronto 15
Moscow 14
Shanghai 13
Dong Ket 12
Lancaster 12
Guangzhou 11
Hangzhou 11
Kocaeli 11
Kunming 11
Mexico City 10
Dallas 9
Falkenstein 9
North York 9
Nürnberg 9
Redondo Beach 9
Chicago 8
Rio de Janeiro 8
San Diego 8
Verona 8
Brooklyn 7
Dhaka 7
Mumbai 7
Ningbo 7
Santa Clara 7
Tokyo 7
Belo Horizonte 6
Chennai 6
Jakarta 6
Johannesburg 6
Rome 6
Turku 6
Zhengzhou 6
Amsterdam 5
Atlanta 5
Baghdad 5
Boardman 5
Council Bluffs 5
Da Nang 5
Frankfurt am Main 5
Guayaquil 5
Haikou 5
Nuremberg 5
Phoenix 5
Poplar 5
Taizhou 5
Asunción 4
Campinas 4
Curitiba 4
Hefei 4
Juiz de Fora 4
London 4
Melbourne 4
Montreal 4
Nairobi 4
Napoli 4
Paris 4
Totale 3.597
Salva come PNG Salva come JPEG
Nome #
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 318
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 263
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 258
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 228
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 218
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 182
Preparazione di colture primarie di fibroblasti di embrione di pollo . 181
microRNAs and human hepatocellular carcinoma 176
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 171
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 164
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 161
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 149
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 147
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 143
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 135
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 134
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 131
Urokinase and c-met are target of miR-23b in human cells. 127
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 125
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 124
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 120
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 118
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 117
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 116
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 116
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 113
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 113
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 111
Tecniche di conservazione delle cellule mediante congelamento. 110
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 109
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 108
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 107
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 107
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 106
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 106
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 105
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 104
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 103
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 98
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 98
RNA interference for urokinase gene in human hepatocellular carcinoma 95
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 95
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 93
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 92
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 92
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 91
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 90
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 86
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 45
Totale 6.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 55 54 21
2021/2022356 9 66 10 26 2 9 10 23 17 35 50 99
2022/2023339 61 13 13 32 31 88 0 24 45 2 15 15
2023/2024361 20 12 28 10 26 90 36 7 72 6 4 50
2024/2025849 2 19 4 117 83 114 44 15 117 33 162 139
2025/20261.519 174 234 131 241 166 111 208 58 90 106 0 0
Totale 6.499